66 phenotypes from 12 alleles in 16 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cdk4+/Cdk4+ Tg(Mt1-Hgf)#Lmb/0 B6.Cg-Cdk4tm1.1Bbd Tg(Mt1-Hgf)#Lmb	abnormal axillary lymph node morphology	J:111992
	abnormal inguinal lymph node morphology	J:111992
	increased incidence of tumors by chemical induction	J:111992
	increased metastatic potential	J:111992
	increased skin tumor incidence	J:111992
Hgftm1.1Tbf/Hgftm1.1Tbf B6.Cg-Hgftm1.1Tbf/Tbf	abnormal strial intermediate cell morphology	J:289982
	decreased endocochlear potential	J:289982
	impaired hearing	J:289982
	thin stria vascularis	J:289982
Hgftm1Cbm/Hgf+ involves: 129P2/OlaHsd * C57BL/6	small liver	J:23170
Hgftm1Cbm/Hgftm1Cbm involves: 129P2/OlaHsd * C57BL/6	abnormal hepatocyte morphology	J:23170
	abnormal liver morphology	J:23170
	abnormal placenta morphology	J:23170
	decreased erythrocyte cell number	J:23170
	decreased fetal weight	J:23170
	decreased trophoblast giant cell number	J:23170
	dilated liver sinusoidal space	J:23170
	disorganized placental labyrinth	J:23170
	dissociated hepatocytes	J:23170
	internal hemorrhage	J:23170
	irregular heartbeat	J:23170
	lethality throughout fetal growth and development, complete penetrance	J:23170
	liver hypoplasia	J:23170
	small liver	J:23170
Hgftm1Jmw/Hgftm1Jmw involves: 129S1/Sv * 129X1/SvJ * C57BL/6	decreased hepatocyte proliferation	J:97145
Hgftm1Jmw/Hgftm1Jmw Tg(Mx1-cre)29-4Her/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL	decreased hepatocyte proliferation	J:97145
	impaired liver regeneration	J:97145
Hgftm1Jmw/Hgftm1Jmw Tg(Pax2-cre)1Akg/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1	abnormal strial intermediate cell morphology	J:289982
Hgftm1Kita/Hgftm1Kita involves: 129S4/SvJae * C57BL/6	abnormal placental labyrinth vasculature morphology	J:23171
	decreased embryo size	J:23171
	decreased trophoblast giant cell number	J:23171
	lethality throughout fetal growth and development, complete penetrance	J:23171
	small liver	J:23171
	small placenta	J:23171
Hgftm1Tbf/Hgftm1Tbf B6.Cg-Hgftm1Tbf/Tbf	abnormal distortion product otoacoustic emission	J:289982
	abnormal organ of Corti supporting cell morphology	J:289982
	abnormal stria vascularis morphology	J:289982
	abnormal strial intermediate cell morphology	J:289982
	normal behavior/neurological phenotype	J:289982
	cochlear outer hair cell degeneration	J:289982
	decreased cochlear outer hair cell number	J:289982
	decreased endocochlear potential	J:289982
	impaired hearing	J:289982
	organ of Corti degeneration	J:289982
	spiral ligament degeneration	J:289982
	thin stria vascularis	J:289982
Tg(CKMM-tTA)A3Rhvh/0 Tg(tetO-Hgf,-EGFP)24Tcre/0 involves: FVB	abnormal skeletal muscle fiber morphology	J:237183
	decreased skeletal muscle fiber size	J:237183
	increased satellite cell number	J:237183
Tg(Ggt1-tTA)#Agoc/0 Tg(tetO/CMV-Hgf)#Agoc/0 involves: CD-1	decreased susceptibility to kidney reperfusion injury	J:130310
Tg(Hgf)1Paus/0 Not Specified	abnormal hair cycle catagen phase	J:65035
	increased hair follicle number	J:65035
	premature hair follicle generation	J:65035
	thick skin	J:65035
Tg(Mt1-Hgf)19Lmb/0 involves: C57BL/6 * CBA * FVB/N	increased skin tumor incidence	J:122181
	normal neoplasm	J:122181
Tg(Mt1-Hgf)19Lmb/0 involves: C57BL/6 * FVB/N	abnormal extracutaneous pigmentation	J:34022
	abnormal melanoblast migration	J:34022
	ectopic melanocytes	J:34022
	ectopic skeletal muscle	J:34022
	hyperpigmentation	J:34022
Tg(Mt1-Hgf)19Lmb/0 involves: FVB/N	abnormal spinal cord ventral horn morphology	J:50947
	ectopic melanocytes	J:50947
	ectopic skeletal muscle	J:34022
	hindlimb paralysis	J:34022
	increased cutaneous melanoma incidence	J:50947
	increased melanoma incidence	J:50947
	increased metastatic potential	J:50947
	intestinal obstruction	J:34022
	kidney failure	J:34022
	premature death	J:34022
Tg(Mt1-Hgf)37Lmb/0 involves: C57BL/6 * FVB/N	hyperpigmentation	J:34022
Tg(Mt1-Hgf)37Lmb/0 involves: FVB/N	intestinal obstruction	J:34022
	kidney failure	J:34022
	premature death	J:34022
Tg(Mt1-Hgf)#Lmb/0 B6.FVB-Tg(Mt1-Hgf)#Lmb	hyperpigmentation	J:111992
	increased ear pigmentation	J:111992
	increased foot pigmentation	J:111992
	reduced female fertility	J:111992
Tg(Wap-Hgf)402Mig/0 FVB/N-Tg(Wap-Hgf)402Mig	increased mammary adenocarcinoma incidence	J:206839
	increased mammary gland tumor incidence in breeding females	J:206839
Tg(Wap-Hgf)402Mig/0 involves: FVB/N	abnormal branching of the mammary ductal tree	J:86776
	abnormal mammary gland morphology	J:86776
	increased mammary adenocarcinoma incidence	J:86776
	increased mammary gland tumor incidence in breeding females	J:86776
	increased mammary gland tumor incidence in virgin females	J:86776
	increased metastatic potential	J:86776
	mammary gland duct hyperplasia	J:86776